Summary

Nuclear Imaging Devices Market – Scope of Report
TMR’s report on the global nuclear imaging devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nuclear imaging devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nuclear imaging devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nuclear imaging devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nuclear imaging devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nuclear imaging devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nuclear imaging devices market.

The report delves into the competitive landscape of the global nuclear imaging devices market. Key players operating in the global nuclear imaging devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nuclear imaging devices market profiled in this report.

Key Questions Answered in Global nuclear imaging devices Market Report
• What is the sales/revenue generated by nuclear imaging devices across all regions during the forecast period?
• What are the opportunities in the global nuclear imaging devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Nuclear Imaging Devices Market – Research Objectives and Research Approach
The comprehensive report on the global nuclear imaging devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nuclear imaging devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nuclear imaging devices market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nuclear Imaging Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nuclear Imaging Device Market Analysis and Forecasts, 2017 - 2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario
5.2. Technological Advancements
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry
6. Global Nuclear Imaging Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017 - 2031
6.3.1. PET Devices
6.3.1.1. Standalone PET
6.3.1.2. PET/CT
6.3.1.3. PET/MRI
6.3.2. SPECT Devices
6.3.2.1. Standalone SPECT
6.3.2.2. SPECT/CT
6.3.2.3. SPECT/MRI
6.3.3. Planar Imaging Devices
6.4. Market Attractiveness Analysis, by Product Type
7. Global Nuclear Imaging Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017 - 2031
7.3.1. Oncology
7.3.2. Cardiology
7.3.3. Neurology
7.3.4. Others (Nephrology, Immunology, etc.)
7.4. Market Attractiveness Analysis, by Application
8. Global Nuclear Imaging Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017 - 2031
8.3.1. Hospitals
8.3.2. Imaging Centers
8.3.3. Academic and Research Centers
8.3.4. Others (Clinics, CROs, etc.)
8.4. Market Attractiveness Analysis, by End-user
9. Global Nuclear Imaging Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017 - 2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Nuclear Imaging Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017 - 2031
10.2.1. PET Devices
10.2.1.1. Standalone PET
10.2.1.2. PET/CT
10.2.1.3. PET/MRI
10.2.2. SPECT Devices
10.2.2.1. Standalone SPECT
10.2.2.2. SPECT/CT
10.2.2.3. SPECT/MRI
10.2.3. Planar Imaging Devices
10.3. Market Value Forecast, by Application, 2017 - 2031
10.3.1. Oncology
10.3.2. Cardiology
10.3.3. Neurology
10.3.4. Others (Nephrology, Immunology, etc.)
10.4. Market Value Forecast, by End-user, 2017 - 2031
10.4.1. Hospitals
10.4.2. Imaging Centers
10.4.3. Academic and Research Centers
10.4.4. Others (Clinics, CROs, etc.)
10.5. Market Value Forecast, by Country, 2017 - 2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Nuclear Imaging Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017 - 2031
11.2.1. PET Devices
11.2.1.1. Standalone PET
11.2.1.2. PET/CT
11.2.1.3. PET/MRI
11.2.2. SPECT Devices
11.2.2.1. Standalone SPECT
11.2.2.2. SPECT/CT
11.2.2.3. SPECT/MRI
11.2.3. Planar Imaging Devices
11.3. Market Value Forecast, by Application, 2017 - 2031
11.3.1. Oncology
11.3.2. Cardiology
11.3.3. Neurology
11.3.4. Others (Nephrology, Immunology, etc.)
11.4. Market Value Forecast, by End-user, 2017 - 2031
11.4.1. Hospitals
11.4.2. Imaging Centers
11.4.3. Academic and Research Centers
11.4.4. Others (Clinics, CROs, etc.)
11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nuclear Imaging Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017 - 2031
12.2.1. PET Devices
12.2.1.1. Standalone PET
12.2.1.2. PET/CT
12.2.1.3. PET/MRI
12.2.2. SPECT Devices
12.2.2.1. Standalone SPECT
12.2.2.2. SPECT/CT
12.2.2.3. SPECT/MRI
12.2.3. Planar Imaging Devices
12.3. Market Value Forecast, by Application, 2017 - 2031
12.3.1. Oncology
12.3.2. Cardiology
12.3.3. Neurology
12.3.4. Others (Nephrology, Immunology, etc.)
12.4. Market Value Forecast, by End-user, 2017 - 2031
12.4.1. Hospitals
12.4.2. Imaging Centers
12.4.3. Academic and Research Centers
12.4.4. Others (Clinics, CROs, etc.)
12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nuclear Imaging Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017 - 2031
13.2.1. PET Devices
13.2.1.1. Standalone PET
13.2.1.2. PET/CT
13.2.1.3. PET/MRI
13.2.2. SPECT Devices
13.2.2.1. Standalone SPECT
13.2.2.2. SPECT/CT
13.2.2.3. SPECT/MRI
13.2.3. Planar Imaging Devices
13.3. Market Value Forecast, by Application, 2017 - 2031
13.3.1. Oncology
13.3.2. Cardiology
13.3.3. Neurology
13.3.4. Others (Nephrology, Immunology, etc.)
13.4. Market Value Forecast, by End-user, 2017 - 2031
13.4.1. Hospitals
13.4.2. Imaging Centers
13.4.3. Academic and Research Centers
13.4.4. Others (Clinics, CROs, etc.)
13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nuclear Imaging Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017 - 2031
14.2.1. PET Devices
14.2.1.1. Standalone PET
14.2.1.2. PET/CT
14.2.1.3. PET/MRI
14.2.2. SPECT Devices
14.2.2.1. Standalone SPECT
14.2.2.2. SPECT/CT
14.2.2.3. SPECT/MRI
14.2.3. Planar Imaging Devices
14.3. Market Value Forecast, by Application, 2017 - 2031
14.3.1. Oncology
14.3.2. Cardiology
14.3.3. Neurology
14.3.4. Others (Nephrology, Immunology, etc.)
14.4. Market Value Forecast, by End-user, 2017 - 2031
14.4.1. Hospitals
14.4.2. Imaging Centers
14.4.3. Academic and Research Centers
14.4.4. Others (Clinics, CROs, etc.)
14.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Koninklijke Philips N.V.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. GE Healthcare
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Canon Medical Systems Corporation
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Siemens Healthineers AG
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Shimadzu Corporation
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. MR Solutions
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Neusoft Medical Systems Co., Ltd.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Mediso Ltd.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. MiE GmbH
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments